World Primary Immunodeficiency (PI) Week, April 23 - 29

Thursday, April 26, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Announcing guidelines to improve patient care and treatments

TORONTO, April 26, 2018 /CNW/ - World PI Week is an

international movement to bring together patients, families and health care professionals to raise awareness, and improve diagnosis and treatment of Primary Immunodeficiency (PI). www.worldpiweek.org

PI occurs when an individual is born

with a broken or completely missing immune system. It is a genetic malfunction and can affect just one cell or many part of the immune system. The World Health Organization recognizes more than 350 genetic defects and disorders of the immune system. There are ten warning signs every parent should know. www.immunodeficiency.ca

To mark #WorldPIWeek, (Test, Diagnosis, Treat), Immunodeficiency Canada announces the publication of Immunoglobulin Replacement Therapy Guidelines for patients care. This therapy is made from human blood and plasma donations. Many PI patients are dependent upon this therapy as there is no other treatment.

Immunodeficiency Canada brought together a national group of Canadian immunologists. With their experience and knowledge this team formulated a set of unanimously agreed upon recommendations for the use of Immunoglobulin Replacement Therapy. The recommendations were published in the Lymphosign Journal, December 2017.  It is now the standard for diagnostic and treatment centres of Primary Immunodeficiency across Canada.

Lymphosign Journal is the official journal of Immunodeficiency Canada. It publishes novel clinical, translational, and basic research in the fields of immunology, gastroenterology, neurology, dermatology, rheumatology, hematology, and infectious disease.  www.lymphosign.com

"Immunodeficiency Canada has a direct impact on the care and treatment of patients with Primary Immunodeficiency, and works to provide the best treatments for patients based on science. It is our hope that governments across Canada adopt these guidelines" Richard Thompson, CEO

Immunodeficiency Canada is very appreciative of the contributions of Drs. Stephen Betschel, Peter Dent, Elie Haddad, Alison Haynes, Thomas Issekutz, Bruce Mazer, Chaim M. Roifman, Bob Schellenberg, Gordon Sussman, Stuart Turvey, Susan Waserman and Ms Brenda Reid.

SOURCE Immunodeficiency Canada

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store